Efficacy and safety of intravenous sulbactam/ampicillin 3 g 4 times daily in Japanese adults with moderate to severe community-acquired pneumonia: A multicenter, open-label, uncontrolled study

2015 ◽  
Vol 21 (3) ◽  
pp. 182-188 ◽  
Author(s):  
Shigeru Kohno ◽  
Kazuhiro Tateda ◽  
Hiroshige Mikamo ◽  
Jun-ichi Kadota ◽  
Yoshihito Niki ◽  
...  
Keyword(s):  
Community Acquired Pneumonia ◽  
Efficacy And Safety ◽  
Open Label ◽  
Uncontrolled Study ◽  
Japanese Adults ◽  
Severe Community Acquired Pneumonia

scholarly journals Efficacy and safety of glucocorticoids in the treatment of severe community-acquired pneumonia

Medicine ◽  
2019 ◽  
Vol 98 (26) ◽  
pp. e16239 ◽  
Author(s):  
Shan Jiang ◽  
Tiecheng Liu ◽  
Yuxin Hu ◽  
Ranwei Li ◽  
Xin Di ◽  
...  
Keyword(s):  
Community Acquired Pneumonia ◽  
Efficacy And Safety ◽  
Severe Community Acquired Pneumonia

scholarly journals Efficacy and safety of adjunctive corticosteroids therapy for patients with severe community-acquired pneumonia

Medicine ◽  
2019 ◽  
Vol 98 (13) ◽  
pp. e14636 ◽  
Author(s):  
Jing Huang ◽  
Jiquan Guo ◽  
Hongtao Li ◽  
Weibin Huang ◽  
Tiantuo Zhang
Keyword(s):  
Community Acquired Pneumonia ◽  
Efficacy And Safety ◽  
Severe Community Acquired Pneumonia

scholarly journals Community-acquired pneumonia in elderly patients: the effectiveness of antimicrobial therapy regimens.

2019 ◽  
Vol 21 (3) ◽  
pp. 60-62
Author(s):  
I Ts Kulagina ◽  
V I Likhodii ◽  
A A Zaitsev
Keyword(s):  
Clinical Efficacy ◽  
Clinical Laboratory ◽  
Age Groups ◽  
Community Acquired Pneumonia ◽  
Comprehensive Analysis ◽  
Efficacy And Safety ◽  
Case Histories ◽  
Radiological Data ◽  
Amoxicillin Clavulanate ◽  
Severe Community Acquired Pneumonia

The clinical efficacy of using «protected» aminopenicillins (amoxicillin/clavulanate, amoxicillin/sulbactam) and the 3rd generation cephalosporins in the treatment of mild community-acquired pneumonia in patients older than 60 years in hospital has been evaluated. Analyzed 71 case histories. The assessment was carried out on the basis of a comprehensive analysis of clinical, laboratory and radiological data. A comparative analysis of the clinical efficacy and safety of the antibiotic regimens under study demonstrated the obvious advantage of using «protected» aminopenicillins over the existing practice of treating non-severe community-acquired pneumonia in patients of older age groups.

Sign in / Sign up

Export Citation Format

Share Document